Menopause

France-based Omena Secures €800K in Seed Funding to Advance Menopause Support App

Omena, a Paris-based FemTech startup, has secured an €800K seed investment, marking its second significant fundraising effort following a €400K pre-seed round in 2021. The company focuses on providing comprehensive support and services to menopausal women through its app. The funding round drew contributions from business angels and family offices, including prominent returning investors such as Alexandre Lebrun, founder of AI healthtech…

Pandia Health Expands Services to Include Menopause Care

Pandia Health, a company known for its birth control treatment and delivery services, is extending its healthcare offerings to include hormonal treatment for menopause. This expansion adds a crucial service to Pandia Health’s portfolio, addressing the needs of mid-life women alongside its existing services for birth control and acne treatment. The company announced today its new Chief Executive Officer, Alice Eweida, who previously…

Pvolve and University of Exeter Release Study on Exercise’s Impact on Pre and Post-Menopausal Women

Pvolve, an omnichannel fitness company known for its functional fitness method, announced the initial findings of a clinical study conducted by the University of Exeter. The study, titled the Healthy Aging Study, examines the impact of Pvolve’s low-impact, resistance-based workouts on women aged 40 and above, comparing the results to those from standard fitness routines. The study addresses a critical gap in…

Bayer Announces Positive Phase III Results for Non-Hormonal Treatment in Menopause-Related Vasomotor Symptoms

German pharmaceutical company Bayer recently announced positive results from two Phase III trials of its new menopausal relief drug, elinzanetant. The drug aims to reduce vasomotor symptoms, particularly hot flashes, which are common during menopause. The announcement is significant for Bayer’s pharmaceutical division following a series of challenges in drug development. The clinical trials demonstrated that elinzanetant significantly reduces the frequency and…

Dr. Reddy’s Acquires Menopause Supplement Brand MenoLabs from Amyris in Chapter 11 Auction

Dr. Reddy’s Laboratories, a global pharmaceutical company headquartered in India, has acquired MenoLabs, a women’s health and dietary supplement brand, as part of Amyris Chapter 11 sales process. This acquisition was conducted through an auction, with Dr. Reddy’s successfully bidding $3 million for the women’s supplements label according to court documents. MenoLabs’ portfolio, now a part of Dr. Reddy’s offerings, includes seven…

Astellas’ VEOZAH Wins EC Approval to Treat Menopause-Related Hot Flashes

Astellas Pharma has announced the approval of VEOZA (fezolinetant) by the European Commission for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause. Vasomotor symptoms, which include hot flashes and night sweats, are common during menopause. Studies indicate that more than half of women between the ages of 40 and 64 in Europe experience VMS, with some areas reporting…

OOVA Launches Perimenopause Hormone Kit with Estrogen Biomarker and Real-Time Data Tracking App

OOVA, a women’s health platform specializing in remote hormone monitoring, has unveiled its new at-home Perimenopause Hormone Kit. The kit, unique in its approach according to the company, features urine-based multi-hormone biomarkers, including estrogen (E3G), and is complemented by an app that offers real-time data tracking. Differing from traditional blood or FSH-only urine tests, the OOVA kit enables a comprehensive 15-day hormone…

Bone Health Technologies Receives New Patent for Its Wearable Treatment for Osteoporosis in Post-Menopausal Women 

Healthtech company Bone Health Technologies has recently been awarded its fourth patent, marking a significant milestone in the journey of its product, Osteoboost. The wearable device is at the forefront of addressing osteopenia and osteoporosis in post-menopausal women, two conditions that significantly impact bone health. Osteoboost’s design and innovative approach have made it the first device of its kind to demonstrate a…